| 22nd Sep 2017 7:00 am |
RNS |
Verseon closes PACE financing for its new facility |
| 7th Aug 2017 7:00 am |
RNS |
Additional Listing and Total Voting Rights |
| 26th Jun 2017 7:00 am |
RNS |
Verseon presents data on DME program at BIO 2017 |
| 12th Jun 2017 7:00 am |
RNS |
Verseon to present drug programs at BIO 2017 |
| 6th Jun 2017 8:15 am |
RNS |
Transaction in Own Shares and Total Voting Rights |
| 2nd May 2017 7:00 am |
RNS |
Additional Listing & Total Voting Rights |
| 26th Apr 2017 7:00 am |
RNS |
TR-1 Notification of Major Interest in Shares |
| 26th Apr 2017 7:00 am |
RNS |
Result of 2017 Annual General Meeting |
| 3rd Apr 2017 7:00 am |
RNS |
Announcement of 2017 Annual General Meeting |
| 30th Mar 2017 7:00 am |
RNS |
Verseon to present anticoagulants at ACS 2017 |
| 20th Mar 2017 7:00 am |
RNS |
BIO-Europe Spring: Verseon presents anticoagulants |
| 13th Mar 2017 7:00 am |
RNS |
Final Results |
| 30th Jan 2017 7:00 am |
RNS |
Additional Listing & Total Voting Rights |
| 4th Jan 2017 7:00 am |
RNS |
Verseon granted US patents for its inhibitors |
| 6th Dec 2016 7:00 am |
RNS |
Lower bleeding risk of Verseon anticoagulants |
| 23rd Nov 2016 7:03 am |
RNS |
Verseon anticoagulants preserve platelet function |
| 16th Nov 2016 7:00 am |
RNS |
Additional Listing & Total Voting Rights |
| 14th Nov 2016 7:00 am |
RNS |
New anticoagulant data to be presented at AHA 2016 |
| 7th Nov 2016 7:00 am |
RNS |
Appointment of Corporate Brokers |
| 31st Oct 2016 7:00 am |
RNS |
Additional Listing & Total Voting Rights |
| 27th Oct 2016 8:41 am |
RNS |
Additional Listing & Total Voting Rights |
| 21st Sep 2016 7:00 am |
RNS |
Director/PDMR Shareholding |
| 12th Sep 2016 7:00 am |
RNS |
Additional Listing & Total Voting Rights |
| 8th Sep 2016 7:00 am |
RNS |
TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES |
| 5th Sep 2016 7:00 am |
RNS |
Interim Results |
| 9th Aug 2016 11:40 am |
RNS |
Additional Listing & Total Voting Rights |
| 22nd Jun 2016 7:00 am |
RNS |
Additional Listing & Total Voting Rights |
| 6th Jun 2016 7:00 am |
RNS |
Verseon to Present Latest Anticoagulant Results |
| 27th Apr 2016 7:00 am |
RNS |
Additional Listing & Total Voting Rights |
| 21st Apr 2016 7:00 am |
RNS |
Result of AGM |
| 7th Apr 2016 7:00 am |
RNS |
Notice of AGM |
| 6th Apr 2016 7:00 am |
RNS |
TR-1: Notification of Major Interest in Shares |
| 4th Apr 2016 7:00 am |
RNS |
Verseon to present additional results at BioEurope |
| 21st Mar 2016 7:00 am |
RNS |
Holdings in Company |
| 17th Mar 2016 7:00 am |
RNS |
Additional Listing & Total Voting Rights |
| 7th Mar 2016 7:00 am |
RNS |
Final Results |
| 1st Mar 2016 7:00 am |
RNS |
Additional Listing & Total Voting Rights |
| 29th Feb 2016 7:00 am |
RNS |
Verseon presents low bleeding risk anticoagulants |
| 10th Feb 2016 7:00 am |
RNS |
Verseon to present new preclinical results at ICHB |
| 4th Feb 2016 7:00 am |
RNS |
Additional Listing & Total Voting Rights |
